日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Wild-type MIC distribution and evaluation of epidemiological cut-offs of second-line TB-drugs in susceptible and MDR-TB clinical isolates from Chennai, India

印度钦奈市敏感和耐多药结核病临床分离株中野生型结核分枝杆菌最小抑菌浓度(MIC)分布及二线抗结核药物流行病学临界值的评估

Dusthackeer, Azger; Balasubramanian, Mahizhaveni; Rajadas, Sam Ebenezer; Nirmal, Christy Rosaline; Elango, Padmasini; Thiruvengadam, Kannan; Saadhali, Shainaba A; Shanmugam, Sivakumar

Editorial: Recent advancements in the research models of infectious diseases

社论:传染病研究模型的最新进展

Rajadas, Sam Ebenezer; Nirmal, Christy Rosaline; Dusthackeer, Azger; Harshavardhan, Shakila; Parthasarathy, Krupakar

Biomolecular Interaction of Carnosine and Anti-TB Drug: Preparation of Functional Biopeptide-Based Nanocomposites and Characterization through In Vitro and In Silico Investigations

肌肽与抗结核药物的生物分子相互作用:功能性生物肽基纳米复合材料的制备及体外和计算机模拟表征

Nagarajan, Usharani; Naha, Aniket; Ashok, Gayathri; Balasubramanian, Angayarkanni; Ramaiah, Sudha; V Kanth, Swarna; Dusthackeer, Azger; Anbarasu, Anand; Natarajan, Saravanan

Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis

rpoB基因突变和利福平耐药水平对利福平耐药结核病治疗结果的影响

Jose Vadakunnel, Maria; Nehru, Vijayalakshmi Jawaharlal; Brammacharry, Usharani; Ramachandra, Venkateswari; Palavesam, Suganthi; Muthukumar, Anbazhagi; Mani, Balasundaram Revathi; R, Sriramkumar S; Pradhabane, Gunavathy; Vn, Azger Dusthackeer; Subramani, Sangeetha; Muthaiah, Muthuraj; Soundappan, Govindarajan

Multicentric validation of the PathoDetect™ MTB RIF & INH assay for simultaneous detection of Mycobacterium tuberculosis, & drug resistance to rifampicin & isoniazid in presumptive pulmonary tuberculosis & drug-resistant TB patients

对 PathoDetect™ MTB RIF & INH 检测方法进行多中心验证,以同时检测疑似肺结核和耐药结核病患者中的结核分枝杆菌及其对利福平和异烟肼的耐药性。

Choudhary, Hansraj; Malik, Garima; Chauhan, Devendra Singh; Bhalla, Manpreet; Dusthackeer, Azger; Desikan, Prabha; Giri, Sidhartha; Kumar, Sandeep; Jayaprakasam, Madhumathi; Singh, Ajay Vir; Sethi, Prabhpreet; Reza, Md Shakir; Mythily, V; Thiyagarajan, V; Panwalkar, Nikita; Tripathy, Jyotismita; Mani, Devdatt; Singh, Diksha; Ramesh, P M; Chalga, Manjeet Singh; Rani, Rajni; Gupta, Nivedita; Pandey, Ravindra Mohan; Singh, Manjula

Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study

耐药性肺结核中氟喹诺酮类药物耐药性的风险评估和传播:一项回顾性基因组流行病学研究

Nehru, Vijayalakshmi Jawaharlal; Jose Vandakunnel, Maria; Brammacharry, Usharani; Ramachandra, Venkateswari; Pradhabane, Gunavathy; Mani, Balasundaram Revathi; Vn, Azger Dusthackeer; Muthaiah, Muthuraj

3,5-disubstituted pyridines with potent activity against drug-resistant Mycobacterium tuberculosis clinical isolates

3,5-二取代吡啶类化合物对耐药结核分枝杆菌临床分离株具有强效活性

Sangu, Komal G; Azger Dusthackeer, Vijayan N; Singh, Vishal K; Maykalwar, Shivani; Krishna, Eruva Vamshi; Angayarkanni, Balasubramanian; Maitra, Rahul; Chopra, Sidharth; Misra, Sunil; Rode, Haridas B

In-vivo studies on Transitmycin, a potent Mycobacterium tuberculosis inhibitor

对强效结核分枝杆菌抑制剂Transitmycin的体内研究

Mondal, Rajesh; Dusthackeer V N, Azger; Kannan, Palaniyandi; Singh, Amit Kumar; Thiruvengadam, Kannan; Manikkam, Radhakrishnan; A S, Shainaba; Balasubramanian, Mahizhaveni; Elango, Padmasini; Ebenezer Rajadas, Sam; Bharadwaj, Dinesh; Arumugam, Gandarvakottai Senthilkumar; Ganesan, Suresh; Kumar A K, Hemanth; Singh, Manjula; Patil, Shripad; U C A, Jaleel; Doble, Mukesh; R, Balagurunathan; Tripathy, Srikanth Prasad; Kumar, Vanaja

Dodecanoic acid & palmitic acid disarms rifampicin resistance by putatively targeting mycobacterial efflux pump Rv1218c

十二烷酸和棕榈酸可能通过靶向分枝杆菌外排泵Rv1218c来解除利福平耐药性。

Nirmal, Christy Rosaline; Rajadas, Sam Ebenezer; Balasubramanian, Mahizhaveni; Magdaline, Divya; Chilamakuru, Naresh Babu; Dinesh, Rajkumar; Radhakrishnan, A; Paraman, Ramalingam; Mondal, Rajesh; Azger Dusthackeer, V N

Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance

深入探讨药物发现策略的最新进展以及对抗耐药性的未开发药物靶点。

Peraman, Ramalingam; Sure, Sathish Kumar; Dusthackeer, V N Azger; Chilamakuru, Naresh Babu; Yiragamreddy, Padmanabha Reddy; Pokuri, Chiranjeevi; Kutagulla, Vinay Kumar; Chinni, Santhivardhan